Article

Neurosteroid Levels in GBA and Non-mutated PD: A Possible Factor Influencing Clinical Phenotype?

2024-07-24

Abstract excerpt

Neurosteroids are pleiotropic molecules involved in various neurodegenerative diseases with neuroinflammation. We assessed neurosteroids serum levels in a cohort of Parkinson’s Disease (PD) patients with heterozygous glucocerebrosidase (GBA) mutations (GBA-PD) compared with matched cohorts of consecutive non-mutated PD (NM-PD) patients, and healthy subjects with (GBA-C) and without (NM-HC) GBA mutations. A c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c2c80647-6795-53ad-a383-d877c4b49139
DOI: 10.20944/preprints202407.1915.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Neurosteroid Levels in GBA and Non-mutated PD: A Possible Factor Influencing Clinical Phenotype?DOI 10.20944/preprints202407.1915.v1Read

Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson's Disease: A Possible Factor Influencing Clinical Phenotype?Semantic proximity Read

Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.Semantic proximity Read

Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutationSemantic proximity Read

GBA mutations, glucosylceramide and Parkinson's disease.Semantic proximity Read

[The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].Semantic proximity Read

Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.Semantic proximity Read

Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.Semantic proximity Read

Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.Semantic proximity Read

Shared and Distinct Lipid Profiles in amygdala from Sporadic and GBA-associated Parkinson’s DiseasesSemantic proximity Read

Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations.Semantic proximity Read

Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting CarriersSemantic proximity Read

Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?Semantic proximity Read